Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Edoxaban, sold under the brand name Lixiana among others, is an anticoagulant medication and a direct factor Xa inhibitor. It is taken by mouth.
Applications, Contraindications and notes & Pharmacokinetics
Explore the main themes, entities and connections around Edoxaban. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
approved blood anticoagulant anticoagulants embolism bleeding factor also use warfarin urine overdose mouth administration ces1 cyp3a4 hydrolysis risk people may
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Edoxaban | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Edoxaban | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Edoxaban | ATC code | B01AF03 (WHO) | 1.00 | infobox |
| Edoxaban | Bioavailability | 62%; Tmax 1–2 hours | 1.00 | infobox |
| Edoxaban | CAS Number | 480449-70-5 N | 1.00 | infobox |
| Edoxaban | ChEBI | CHEBI:85973 N | 1.00 | infobox |
| Edoxaban | ChemSpider | 8456212 N | 1.00 | infobox |
| Edoxaban | CompTox Dashboard (EPA) | DTXSID50197398 | 1.00 | infobox |
| Edoxaban | DrugBank | DB09075 N | 1.00 | infobox |
| Edoxaban | Elimination half-life | 10–14 hours | 1.00 | infobox |
| Edoxaban | Excretion | 62% feces, 35% urine | 1.00 | infobox |
| Edoxaban | Formula | C24H30ClN7O4S | 1.00 | infobox |
| Edoxaban | IUPHAR/BPS | 7575 | 1.00 | infobox |
| Edoxaban | KEGG | D09710 N | 1.00 | infobox |
| Edoxaban | Legal status | CA: ℞-only | 1.00 | infobox |
| Edoxaban | Legal status | US: ℞-only | 1.00 | infobox |
| Edoxaban | Legal status | EU: Rx-only | 1.00 | infobox |
| Edoxaban | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Edoxaban | License data | US DailyMed: Edoxaban | 1.00 | infobox |
| Edoxaban | MedlinePlus | a614055 | 1.00 | infobox |
| Edoxaban | Metabolism | minimal CES1, CYP3A4/5, hydrolysis, glucuronidation | 1.00 | infobox |
| Edoxaban | Molar mass | 548.06 g·mol−1 | 1.00 | infobox |
| Edoxaban | Other names | DU-176b | 1.00 | infobox |
| Edoxaban | Protein binding | 55% | 1.00 | infobox |
| Edoxaban | PubChem CID | 10280735 | 1.00 | infobox |
| Edoxaban | Routes of administration | By mouth | 1.00 | infobox |
| Edoxaban | Trade names | Savaysa, Lixiana, Roteas, others | 1.00 | infobox |
| Edoxaban | UNII | NDU3J18APO | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.